This pathogenetic model of depression has evolved since its initial formulation, including now adaptive changes in receptors and the participation of second messengers/signal transduction pathways (cAMP, phosphokinase A, cAMP-response element-binding protein, neurotrophin-mediated pathway, etc.), elements which are explored in connection with the original hypothesis [28,29]. Here, BDNF is linked to depressive symptom measurement.